News und Analysen

Laut einer neuen Untersuchung von Veeva Systems (NYSE: VEEV) sind Kundendaten für europäische Unternehmen der Biowissenschaften von entscheidender Bedeutung für Initiativen zur digitalen

Northwell Health, New York State’s largest health care provider and private employer, and Humana Inc. (NYSE: HUM), a leading health and well-being company, announced a five-year agreement that will

Humana Inc. (NYSE: HUM), a leading health and well-being company, and Humana’s philanthropic arm, The Humana Foundation, have committed more than $2.2 million to COVID-19 relief and hurricane

According to new research from Veeva Systems (NYSE: VEEV), customer data is critical to digital transformation initiatives for European life sciences companies. Findings from the Veeva 2020

Access to quality customer reference data is more important than ever as the life sciences industry shifts to digital engagement, according to new research from Veeva Systems (NYSE: VEEV). Findings

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVac^TM

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in

Pfizer Inc. (NYSE: PFE) announced today positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS)

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Virtual Healthcare Conference on Thursday

Pfizer Inc. (NYSE: PFE) announced today further details regarding the proposed spin-off of its Upjohn Business and the subsequent combination of Mylan and the Upjohn Business to form Viatris Inc

Axsome Therapeutics, Inc. (NASDAQ: AXSM), ein biopharmazeutisches Unternehmen, das neuartige Therapien für die Behandlung von Erkrankungen des Zentralnervensystems (ZNS) entwickelt, und Veeva

Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act

Quidel Corporation (NASDAQ:QDEL), provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will host its Quidel

Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Dr. Francesca Domenech Wuttke, Chief Digital Officer bei Almirall, und Alessandro de Luca, CIO des Gesundheitswesens bei Merck KGaA, Darmstadt

DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM – 2:30 PM Eastern). The event

Veeva Systems (NYSE: VEEV) today announced that Dr. Francesca Domenech Wuttke, chief digital officer at Almirall, and Alessandro de Luca, CIO of healthcare at Merck KGaA, Darmstadt, Germany are

Waters Corporation (NYSE:WAT) today introduced the new RADIAN™ ASAP™ System, a novel direct mass detector engineered for non-mass spectrometry (MS) experts to conduct fast and accurate analyses of

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC’s review of the

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020.

Third quarter 2020 results reflect strong sequential growth:

• 
  Revenue of $794

PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer^® New Coronavirus

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third